Tag Archive: Dexamfetamine

May
25

• European drug regulators have recommended market approval for dexamfetamine sulfate as a second-line treatment for attention-deficit/hyperactivity disorder (ADHD)

European drug regulators have recommended market approval for dexamfetamine sulfate as a second-line treatment for attention-deficit/hyperactivity disorder (ADHD) in children. Dexamfetamine sulfate is indicated for children with ADHD aged 6 to 17 years who have not responded to methylphenidate.